Preliminary evidence of the in vitro effects of BDE-47 on innate immune responses in children with autism spectrum disorders

This publication has 57 references indexed in Scilit:

• Neonatal exposure to decabrominated diphenyl ether (PBDE 209) results in changes in BDNF, CaMKII and GAP-43, biochemical substrates of neuronal survival, growth, and synaptogenesis
  NeuroToxicology, 2008
• Maternal Immune Activation Alters Fetal Brain Development through Interleukin-6
  The Journal of Neuroscience, 2007
• A genetic variant that disrupts MET transcription is associated with autism
  Proceedings of the National Academy of Sciences, 2006
• Polybrominated Diphenyl Ethers: A Case Study for Using Biomonitoring Data to Address Risk Assessment Questions
  Environmental Health Perspectives, 2006
• Autism Spectrum Disorders in Relation to Distribution of Hazardous Air Pollutants in the San Francisco Bay Area
  Environmental Health Perspectives, 2006
• The CHARGE Study: An Epidemiologic Investigation of Genetic and EnvironmentalFactors Contributing to Autism
  Environmental Health Perspectives, 2006
• Non-Coplanar PCB-Mediated Modulation of Human Leukocyte Phagocytosis: A New Mechanism for Immunotoxicity
  Journal of Toxicology and Environmental Health, Part A, 2005
• Neuroglial activation and neuroinflammation in the brain of patients with autism
  Annals of Neurology, 2004
• ANALYSIS OF POLYBROMINATED DIPHENYL ETHERS IN SWEDISH HUMAN MILK. A TIME-RELATED TREND STUDY, 1972-1997
  Journal of Toxicology and Environmental Health, Part A, 1999
• Plasma increase of interleukin-12 and interferon-gamma. Pathological significance in autism
  Journal of Neuroimmunology, 1996